Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06170684
NCT06170684Not yet recruitingNot Applicable

Clinical Study of Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer

Beijing Obstetrics and Gynecology Hospital0 sites100 target enrollmentStarted: December 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
100
Primary Endpoint
Complete remission rate
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Exploring the efficacy and pregnancy outcomes of conservative treatment for atypical endometrial hyperplasia and endometrial cancer. Study the factors related to predicting treatment efficacy.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •(1) age ≤ 45 years old, strong desire to preserve reproductive function, and no factors of reproductive dysfunction evaluated before treatment; (2) The pathological type is atypical endometrial hyperplasia or endometrial cancer; (3) Imaging examination confirmed that the tumor was localized to the endometrium; (4) There are follow-up conditions available.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Complete remission rate

Time Frame: 6months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Beijing Obstetrics and Gynecology Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hongyan Ren

Researchers

Beijing Obstetrics and Gynecology Hospital

Similar Trials

Active, not recruiting
Not Applicable
Conservative Management for PAS PilotPlacenta Accreta
NCT05139498University of Utah4
Completed
Not Applicable
Development and Validation of a Therapeutic Decision Aid in Ectopic Pregnancy: GEUDECID StudyTo Validate a Decision Aid for Ectopic Pregnancy
NCT05745831Institut National de la Santé Et de la Recherche Médicale, France109
Recruiting
Not Applicable
Placenta Accreta Spectrum Outcome After Uterine ConservationPlacenta Accreta Spectrum
NCT04866888Alexandria University120
Completed
Phase 2
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol AcetateAtypical Endometrial HyperplasiaEndometrial Carcinoma
NCT00483327NYU Langone Health31
Unknown
Phase 4
Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent FertilityTubal Pregnancy
NCT00137982Hopital Antoine Beclere600